Since the SNPs identified herein increase risk for early onset disease, it would be interesting for future studies to examine hereditary cancers that predispose to PC to determine whether these SNPs are associated with earlier ages of PC development or disease development itself since previous studies provided strong evidence of an increased risk of PC in BRCA2 mutation carriers [41, 42]. This evidence concerns the gene BRCA2 and cancer.